Please login to view this media

  • Talk
  • UK

An Overview of the MSK Strategy in the Covid Context

Description

The presentation begins with Bob Handley introducing Andrew Bennett, the National Clinical Director for Musculoskeletal (MSK) conditions, who shares insights on the MSK strategy developed over the past nine months. Andrew Bennett highlights the overall goal of promoting lifelong MSK health within communities, emphasizing the importance of physical activity for well-being. He discusses the objectives aimed at addressing inequalities in healthcare, ensuring personalized and high-quality healthcare delivery, and fostering shared decision-making.



Bennett details the response to the COVID crisis, explaining how the MSK unit adapted to manage surge capacity while maintaining urgent care pathways. He outlines the need for interconnectivity between different levels of healthcare and describes collaborative efforts with various stakeholders. The presentation also touches upon the importance of engaging with patients and incorporating their lived experiences into the strategy.



As the session progresses, Bennett unveils plans for both restoration of MSK services impacted by COVID and beneficial changes derived from rapid adaptations made during the pandemic. He introduces a crowd-sourcing initiative to gather innovative ideas from the clinical community. The discussion concludes with a call for collaboration in driving these initiatives forward amidst ongoing challenges, highlighting the dedication to enhancing MSK care through a comprehensive and integrated approach.

DOI: 10.1302/3114-210032

Specialties